Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients
Elisabeth Rouits, Michèle Boisdron-Celle, Agnès Dumont, et al.
Clinical Colorectal Cancer
|
June 12, 2012
Individual fluorouracil dose adjustment in FOLFOX based on pharmacokinetic follow-up compared with conventional body-area-surface dosing: a phase II, proof-of-concept study
Olivier Capitain, Andreaa Asevoaia, Michele Boisdron-Celle, et al.
Cancer Letters
|
January 3, 2006
Tumor quantification of several fluoropyrimidines resistance gene expression with a unique quantitative RT-PCR method. Implications for pretherapeutic determination of tumor resistance phenotype
Maud Barbado, Laurence Preisser, Michele Boisdron-Celle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2004
Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer
Laurence Gamelin, Michele Boisdron-Celle, Remy Delva, et al.
Molecular Cancer Therapeutics
|
November 24, 2006
Clinical relevance of different dihydropyrimidine dehydrogenase gene single nucleotide polymorphisms on 5-fluorouracil tolerance
Alain Morel, Michele Boisdron-Celle, Luc Fey, et al.
Molecular Cancer
|
July 8, 2011
Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells
Agnes Basseville, Laurence Preisser, Sophie de Carné Trécesson, et al.
The Journal of Biological Chemistry
|
June 3, 2010
The cdk5 kinase regulates the STAT3 transcription factor to prevent DNA damage upon topoisomerase I inhibition
Sandy Courapied, Hélène Sellier, Sophie de Carné Trécesson, et al.
International Journal of Cancer
|
April 21, 2009
Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages
Dorothée Duluc, Murielle Corvaisier, Simon Blanchard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2007
Predictive factors of oxaliplatin neurotoxicity: the involvement of the oxalate outcome pathway
Laurence Gamelin, Olivier Capitain, Alain Morel, et al.
Molecular Cancer
|
August 5, 2010
Regulation of the Aurora-A gene following topoisomerase I inhibition: implication of the Myc transcription factor
Sandy Courapied, Julia Cherier, Arnaud Vigneron, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients
Elisabeth Rouits, Michèle Boisdron-Celle, Agnès Dumont, et al.
Clinical Colorectal Cancer
|
June 12, 2012
Individual fluorouracil dose adjustment in FOLFOX based on pharmacokinetic follow-up compared with conventional body-area-surface dosing: a phase II, proof-of-concept study
Olivier Capitain, Andreaa Asevoaia, Michele Boisdron-Celle, et al.
Cancer Letters
|
January 3, 2006
Tumor quantification of several fluoropyrimidines resistance gene expression with a unique quantitative RT-PCR method. Implications for pretherapeutic determination of tumor resistance phenotype
Maud Barbado, Laurence Preisser, Michele Boisdron-Celle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2004
Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer
Laurence Gamelin, Michele Boisdron-Celle, Remy Delva, et al.
Molecular Cancer Therapeutics
|
November 24, 2006
Clinical relevance of different dihydropyrimidine dehydrogenase gene single nucleotide polymorphisms on 5-fluorouracil tolerance
Alain Morel, Michele Boisdron-Celle, Luc Fey, et al.
Molecular Cancer
|
July 8, 2011
Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells
Agnes Basseville, Laurence Preisser, Sophie de Carné Trécesson, et al.
The Journal of Biological Chemistry
|
June 3, 2010
The cdk5 kinase regulates the STAT3 transcription factor to prevent DNA damage upon topoisomerase I inhibition
Sandy Courapied, Hélène Sellier, Sophie de Carné Trécesson, et al.
International Journal of Cancer
|
April 21, 2009
Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages
Dorothée Duluc, Murielle Corvaisier, Simon Blanchard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2007
Predictive factors of oxaliplatin neurotoxicity: the involvement of the oxalate outcome pathway
Laurence Gamelin, Olivier Capitain, Alain Morel, et al.
Molecular Cancer
|
August 5, 2010
Regulation of the Aurora-A gene following topoisomerase I inhibition: implication of the Myc transcription factor
Sandy Courapied, Julia Cherier, Arnaud Vigneron, et al.
Page
of 5